HEADER HYDROLASE INHIBITOR 15-APR-08 2K2Y TITLE SOLUTION STRUCTURE OF THE FOLDED DOMAIN OF INTERMEDIATE IIIA OF TICK TITLE 2 CARBOXYPEPTIDASE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CARBOXYPEPTIDASE INHIBITOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 23-61; COMPND 5 SYNONYM: TCI; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RHIPICEPHALUS BURSA; SOURCE 3 ORGANISM_COMMON: TICK; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 6 EXPRESSION_SYSTEM_VECTOR: PBAT-4-OMPA KEYWDS IIIA, BLOOD COAGULATION, FIBRINOLYSIS, METALLOENZYME INHIBITOR, KEYWDS 2 METALLOPROTEASE INHIBITOR, SECRETED, HYDROLASE INHIBITOR EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR D.PANTOJA-UCEDA,F.BLANCO REVDAT 2 19-FEB-20 2K2Y 1 REMARK REVDAT 1 27-JAN-09 2K2Y 0 JRNL AUTH J.L.AROLAS,D.PANTOJA-UCEDA,S.VENTURA,F.J.BLANCO,F.X.AVILES JRNL TITL THE NMR STRUCTURES OF THE MAJOR INTERMEDIATES OF THE JRNL TITL 2 TWO-DOMAIN TICK CARBOXYPEPTIDASE INHIBITOR REVEAL SYMMETRY JRNL TITL 3 IN ITS FOLDING AND UNFOLDING PATHWAYS. JRNL REF J.BIOL.CHEM. V. 283 27110 2008 JRNL REFN ISSN 0021-9258 JRNL PMID 18640980 JRNL DOI 10.1074/JBC.M803978200 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XWINNMR, CYANA REMARK 3 AUTHORS : BRUKER BIOSPIN (XWINNMR), GUNTERT, MUMENTHALER AND REMARK 3 WUTHRICH (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: STANDARD CYANA PROTOCOL OF NOE REMARK 3 ASSIGNMENT AND STRUCTURE CALCULATION. THE 20 CONFORMERS WITH THE REMARK 3 LOWEST FINAL CYANA TARGET FUNCTION VALUES WERE SUBJECT TO REMARK 3 RESTRAINED ENERGY-MINIMIZATION IN EXPLICIT WATER USING AMBER 9.0 REMARK 4 REMARK 4 2K2Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-APR-08. REMARK 100 THE DEPOSITION ID IS D_1000100609. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 3.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.00 MM IIIA, 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H TOCSY; 2D 1H-1H NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XWINNMR, NMRVIEW, CYANA REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 THR A 29 -55.63 -144.29 REMARK 500 2 THR A 29 -55.02 -136.11 REMARK 500 2 ASP A 33 35.60 -92.08 REMARK 500 3 CYS A 16 106.14 -58.24 REMARK 500 3 THR A 29 -63.30 -131.85 REMARK 500 4 CYS A 10 49.56 -151.93 REMARK 500 4 THR A 29 -53.15 -149.56 REMARK 500 5 THR A 29 -74.48 -127.92 REMARK 500 6 ASP A 15 -45.93 -133.04 REMARK 500 6 CYS A 16 104.31 -52.21 REMARK 500 6 THR A 29 -59.79 -135.39 REMARK 500 7 THR A 29 -28.25 -158.85 REMARK 500 8 THR A 29 -61.36 -132.16 REMARK 500 9 THR A 29 -57.18 -122.53 REMARK 500 10 THR A 29 -61.70 -134.22 REMARK 500 11 CYS A 10 76.81 -150.34 REMARK 500 11 THR A 29 -65.61 -133.13 REMARK 500 12 GLU A 2 -51.09 -125.23 REMARK 500 12 GLN A 13 8.70 -69.34 REMARK 500 12 THR A 29 -49.12 -147.27 REMARK 500 13 THR A 29 -41.31 -143.50 REMARK 500 14 THR A 29 -52.62 -148.53 REMARK 500 14 LEU A 37 -72.39 -117.14 REMARK 500 15 CYS A 10 56.45 -141.16 REMARK 500 15 THR A 29 -61.26 -137.53 REMARK 500 16 PHE A 8 -96.59 -90.07 REMARK 500 16 THR A 29 -38.28 -155.55 REMARK 500 17 GLN A 13 3.92 -69.72 REMARK 500 17 THR A 29 -64.28 -126.58 REMARK 500 17 THR A 38 -22.23 -143.59 REMARK 500 18 THR A 29 -60.35 -136.50 REMARK 500 19 CYS A 10 59.02 -152.94 REMARK 500 19 THR A 29 -32.81 -155.82 REMARK 500 20 CYS A 10 72.60 -154.10 REMARK 500 20 THR A 29 -65.03 -130.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2K2X RELATED DB: PDB REMARK 900 RELATED ID: 2K2Z RELATED DB: PDB REMARK 900 RELATED ID: 15730 RELATED DB: BMRB DBREF 2K2Y A 1 39 UNP Q5EPH2 TCI1_RHIBU 23 61 SEQRES 1 A 39 ASN GLU CYS VAL SER LYS GLY PHE GLY CYS LEU PRO GLN SEQRES 2 A 39 SER ASP CYS PRO GLN GLU ALA ARG LEU SER TYR GLY GLY SEQRES 3 A 39 CYS SER THR VAL CYS CYS ASP LEU SER LYS LEU THR GLY HELIX 1 1 ASN A 1 LYS A 6 1 6 HELIX 2 2 LEU A 34 GLY A 39 1 6 SSBOND 1 CYS A 3 CYS A 31 1555 1555 2.04 SSBOND 2 CYS A 10 CYS A 27 1555 1555 2.04 SSBOND 3 CYS A 16 CYS A 32 1555 1555 2.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 124 0 0 2 0 0 0 6 0 0 0 3 END